Literature DB >> 3428354

Effect of excitatory amino acid analogues on the release of D-[3H]aspartate from chick retina.

A M López-Colomé1, P J Roberts.   

Abstract

There is good evidence to suggest that L-glutamate (L-Glu) and/or L-aspartate (L-Asp) might function as excitatory neurotransmitters in the vertebrate retina. Postsynaptic receptors for these compounds have been identified in both plexiform layers by means of physiological and biochemical techniques. However, the presence of excitatory amino acid receptors which could regulate the release of these compounds has not previously been demonstrated. We have now shown that the K+-stimulated, Ca2+-dependent release of [3H]D-aspartate from superfused chick retina is inhibited by L-Glu, N-methyl-D-aspartate (NMDA), kainate (KA) and several other neuroactive analogues. While alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and (+/-)2-amino-5-phosphonovaleric acid both exhibited agonist activity when tested alone, the former substance reversed the inhibition observed with L-Glu and KA whereas the latter effectively antagonized the NMDA-induced inhibition of release, possibly acting as partial agonists. The results demonstrate an interaction of NMDA and AMPA with KA probably at receptors in the chick retina that are involved in the regulation of glutamate/aspartate release.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428354     DOI: 10.1016/0014-2999(87)90080-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Role of the non-enzymatic metabolite of eicosapentaenoic acid, 5-epi-5-F3t-isoprostane in the regulation of [ (3)H]D-aspartate release in isolated bovine retina.

Authors:  Jamal Jamil; Pratik Bankhele; Ankita Salvi; Jaimee E Mannix; Camille Oger; Alexandre Guy; Jean-Marie Galano; Thierry Durand; Ya Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2014-09-25       Impact factor: 3.996

2.  Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases.

Authors:  Guendalina Olivero; Matteo Vergassola; Francesca Cisani; Cesare Usai; Anna Pittaluga
Journal:  Mol Neurobiol       Date:  2019-02-07       Impact factor: 5.590

3.  Regulation of [³H]d-aspartate release by the 5-F(2t)-isoprostane and its 5-epimer in isolated bovine retina.

Authors:  Jamal Jamil; Ashley Wright; Na'cara Harrison; Edem Kegey; Arnecia Faye Flowers; Namonique Jarell Flyod; Casey Kotera; Alexandre Guy; Jean-Marie Galano; Thierry Durand; Ya Fatou Njie-Mbye; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2011-11-13       Impact factor: 3.996

4.  Comparative Effects of Hydrogen Sulfide-Releasing Compounds on [3H]D-Aspartate Release from Bovine Isolated Retinae.

Authors:  Pratik Bankhele; Ankita Salvi; Jamal Jamil; Fatou Njie-Mbye; Sunny Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2018-01-20       Impact factor: 3.996

5.  Human, bovine, and rabbit retinal glutamate-induced [3H]D-aspartate release: role in excitotoxicity.

Authors:  S E Ohia; C A Opere; S O Awe; L Adams; N A Sharif
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

6.  Regulation of [3H] D-aspartate release from mammalian isolated retinae by hydrogen sulfide.

Authors:  Catherine A Opere; Emmanuel M Monjok; Kaustubh H Kulkarni; Ya Fatou Njie; Sunny E Ohia
Journal:  Neurochem Res       Date:  2009-05-07       Impact factor: 3.996

7.  Effect of peroxides on [3H]D-aspartate release from bovine isolated retinae.

Authors:  Angela M LeDay; Sunday O Awe; Kaustubh Kulkarni; Lydia C Harris; Catherine Opere; Alekha Dash; Sunny E Ohia
Journal:  Neurochem Res       Date:  2004-04       Impact factor: 3.996

8.  Thrombin induces Ca2+-dependent glutamate release from RPE cells mediated by PLC/PKC and reverse Na+/Ca2+ exchange.

Authors:  Edith López; Irene Lee-Rivera; Alejandro Alvarez-Arce; Ana María López-Colomé
Journal:  Mol Vis       Date:  2019-10-05       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.